The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings
Abstract
Aims: Recently, several synthetic cannabinoids were identified in herbal mixtures consumed as recreational drugs alternative to cannabis products. The aim was to characterize the acute toxicity of synthetic cannabinoids as experienced by emergency patients. Design: This was a retrospective study targeting patients seeking emergency treatment after recreational use of synthetic cannabinoids. Setting and participants: Patients were selected from the database of the Poisons Information Center F reiburg between September 2008 and February 2011. The inclusion criteria were: hospitalization, available clinical reports and analytical verification of synthetic cannabinoid uptake. In total, 29 patients were included (age 14–30 years, median 19; 25 males, four females). Measurements: Clinical reports were evaluated and synthetic cannabinoids and other drugs were determined analytically. Findings: CP‐47,497‐C8 (one),JWH‐015 (one),JWH‐018 (eight),JWH‐073 (one),JWH‐081 (seven),JWH‐122 (11),JWH‐210 (11),JWH‐250 (four) and AM 694 (one) were quantified in blood samples.JWH‐018 was most common in 2008–9,JWH‐122 in 2010, and JWH‐210 in 2011. Tachycardia, agitation, hallucination, hypertension, minor elevation of blood glucose, hypokalaemia and vomiting were reported most frequently. Chest pain, seizures, myoclonia and acute psychosis were also noted. Conclusions: There appears to have been an increase in use of the extremely potent synthetic cannabinoids JWH‐122 and JWH‐210. Acute toxic symptoms associated with their use are also reported after intake of high doses of cannabis, but agitation, seizures, hypertension, emesis and hypokalaemia seem to be characteristic to the synthetic cannabinoids, which are high‐affinity and high‐efficacy agonists of the CB1 receptor. Thus, these effects are due probably to a strong CB1 receptor stimulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pertwee, R. G., Howlett, A. C., Abood, M. E., Alexander, S. P. H., Di Marzo, V., Elphick, M. R., Greasley, P. J., Hansen, H. S., Kunos, G., Mackie, K., et al. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003004 · Cited by 1,605
Endocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,529
Glass, M., Faull, R. L. M., & Dragunow, M. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00428-9 · Cited by 1,052
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024
Poisoning Severity Score. Grading of Acute Poisoning
Persson, H. E., Sjöberg, G. K., Haines, J. A., & de Garbino, J. P. (1998) · Journal of Toxicology: Clinical Toxicology · doi:10.3109/15563659809028940 · Cited by 940
‘Spice’ and other herbal blends: harmless incense or cannabinoid designer drugs?
Auwärter, V., Dresen, S., Weinmann, W., Müller, M., Pütz, M., & Ferreirós, N. (2009) · Journal of Mass Spectrometry · doi:10.1002/jms.1558 · Cited by 660
Self-citationPharmacological Actions of Cannabinoids
Pertwee, R. G. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_1 · Cited by 597
Showalter, V. M., Compton, D. R., Martin, B. R., & Abood, M. E. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20744-3 · Cited by 571
Howlett, A. C. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00060-6 · Cited by 535
CANNABINOID RECEPTORS AS THERAPEUTIC TARGETS
Mackie, K. (2006) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141254 · Cited by 505
Endocannabinoid Signaling and Long-Term Synaptic Plasticity
Heifets, B. D., & Castillo, P. E. (2009) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163149 · Cited by 482
Compton, D. R., Rice, K. C., De Costa, B. R., Razdan, R. K., Melvin, L. S., Johnson, M. R., & Martin, B. R. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38122-x · Cited by 461
Being stoned: a review of self‐reported cannabis effects
GREEN, B., KAVANAGH, D., & YOUNG, R. (2003) · Drug and Alcohol Review · doi:10.1080/09595230310001613976 · Cited by 390
Cannabis, the mind and society: the hash realities
Murray, R. M., Morrison, P. D., Henquet, C., & Forti, M. D. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2253 · Cited by 322
Cardiovascular System Effects of Marijuana
Jones, R. T. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb06004.x · Cited by 319
Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond
Pertwee, R. G. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00108.x · Cited by 314
Dresen, S., Ferreirós, N., Pütz, M., Westphal, F., Zimmermann, R., & Auwärter, V. (2010) · Journal of Mass Spectrometry · doi:10.1002/jms.1811 · Cited by 309
Self-citationLindigkeit, R., Boehme, A., Eiserloh, I., Luebbecke, M., Wiggermann, M., Ernst, L., & Beuerle, T. (2009) · Forensic Science International · doi:10.1016/j.forsciint.2009.06.008 · Cited by 299
Morrison, P. D., Zois, V., McKeown, D. A., Lee, T. D., Holt, D. W., Powell, J. F., Kapur, S., & Murray, R. M. (2009) · Psychological Medicine · doi:10.1017/s0033291709005522 · Cited by 298
Withdrawal Phenomena and Dependence Syndrome After the Consumption of „Spice Gold“
Zimmermann, U. S., Winkelmann, P. R., Pilhatsch, M., Nees, J. A., Spanagel, R., & Schulz, K. (2009) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2009.0464 · Cited by 278
Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2
Mir, A., Obafemi, A., Young, A., & Kane, C. (2011) · Pediatrics · doi:10.1542/peds.2010-3823 · Cited by 266
Atwood, B. K., Huffman, J., Straiker, A., & Mackie, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00582.x · Cited by 262
Huffman, J. W., Zengin, G., Wu, M.-J., Lu, J., Hynd, G., Bushell, K., Thompson, A. L. S., Bushell, S., Tartal, C., Hurst, D. P., et al. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.09.050 · Cited by 259
Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding
Aung, M. M., Griffin, G., Huffman, J. W., Wu, M.-J., Keel, C., Yang, B., Showalter, V. M., Abood, M. E., & Martin, B. R. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00152-0 · Cited by 254
Effects of Cannabinoids on Neurotransmission
Szabo, B., & Schlicker, E. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_11 · Cited by 252
Self-citationChemical analysis of synthetic cannabinoids as designer drugs in herbal products
Uchiyama, N., Kikura-Hanajiri, R., Ogata, J., & Goda, Y. (2010) · Forensic Science International · doi:10.1016/j.forsciint.2010.01.004 · Cited by 245
Structure-Activity Relationships of Indole- and Pyrrole-Derived Cannabinoids
Wiley, J. L., Compton, D. R., Dai, D., Lainton, J. A. H., Phillips, M., Huffman, J. W., & Martin, B. R. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37496-8 · Cited by 240
“Spice” Girls: Synthetic Cannabinoid Intoxication
Schneir, A. B., Cullen, J., & Ly, B. T. (2011) · The Journal of Emergency Medicine · doi:10.1016/j.jemermed.2010.10.014 · Cited by 215
Severe Toxicity Following Synthetic Cannabinoid Ingestion
Lapoint, J., James, L. P., Moran, C. L., Nelson, L. S., Hoffman, R. S., & Moran, J. H. (2011) · Clinical Toxicology · doi:10.3109/15563650.2011.609822 · Cited by 212
Ames, F. (1958) · Journal of Mental Science · doi:10.1192/bjp.104.437.972 · Cited by 184
Müller, H., Sperling, W., Köhrmann, M., Huttner, H. B., Kornhuber, J., & Maler, J.-M. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2009.12.001 · Cited by 183
Identification of a Cannabinoid Analog as a New Type of Designer Drug in a Herbal Product
Uchiyama, N., Kikura-Hanajiri, R., Kawahara, N., Haishima, Y., & Goda, Y. (2009) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.57.439 · Cited by 172
Cannabidiol-induced intracellular Ca2+ elevations in hippocampal cells
Drysdale, A. J., Ryan, D., Pertwee, R. G., & Platt, B. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.11.008 · Cited by 160
Psychosis Associated With Synthetic Cannabinoid Agonists: A Case Series
Hurst, D., Loeffler, G. H., & McLay, R. N. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11010176 · Cited by 156
Dresen, S., Kneisel, S., Weinmann, W., Zimmermann, R., & Auwärter, V. (2011) · Journal of Mass Spectrometry · doi:10.1002/jms.1877 · Cited by 155
Self-citationHuffman, J. W., Mabon, R., Wu, M., Lu, J., Hart, R., Hurst, D. P., Reggio, P. H., Wiley, J. L., & Martin, B. R. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00451-0 · Cited by 149
Kneisel, S., & Auwärter, V. (2012) · Journal of Mass Spectrometry · doi:10.1002/jms.3020 · Cited by 148
Self-citationVan Laere, K., Goffin, K., Casteels, C., Dupont, P., Mortelmans, L., de Hoon, J., & Bormans, G. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.10.053 · Cited by 142
Melvin, L. S., Milne, G. M., Johnson, M. R., Subramaniam, B., Wilken, G. H., & Howlett, A. C. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13256-2 · Cited by 136
Health consequences of acute and chronic marihuana use
Maykut, M. O. (1985) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(85)90085-5 · Cited by 136
Sontineni, S. P. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1264 · Cited by 136
1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles
Huffman, J. W., Szklennik, P. V., Almond, A., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.06.008 · Cited by 125
Uchiyama, N., Kawamura, M., Kikura‐Hanajiri, R., & Goda, Y. (2010) · Forensic Toxicology · doi:10.1007/s11419-010-0100-3 · Cited by 122
Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation
Young, A. C., Schwarz, E. S., Medina, G., Obafemi, A. I., Feng, S., Kane, C., & Kleinschmidt, K. (2011) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2011.05.013 · Cited by 121
Convulsions Associated with the Use of a Synthetic Cannabinoid Product
Schneir, A., & Baumbacher, T. (2011) · Journal of Medical Toxicology · doi:10.1007/s13181-011-0182-2 · Cited by 119
Three cases of “spice” exposure
Simmons, J. R., Cookman, L., Kang, C., et al. (2011) · Clinical Toxicology · doi:10.3109/15563650.2011.584316 · Cited by 118
ESI-MS/MS library of 1,253 compounds for application in forensic and clinical toxicology
Dresen, S., Gergov, M., Politi, L., Halter, C. C., & Weinmann, W. (2009) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-009-3084-2 · Cited by 106
Nakajima, J., Takahashi, M., Nonaka, R., Seto, T., Suzuki, J., Yoshida, M., Kanai, C., & Hamano, T. (2011) · Forensic Toxicology · doi:10.1007/s11419-011-0114-5 · Cited by 101
A cannabinoid derived prototypical analgesic
Melvin, L. S., Johnson, M. R., Harbert, C. A., Milne, G. M., & Weissman, A. (1984) · Journal of Medicinal Chemistry · doi:10.1021/jm00367a013 · Cited by 97
Intoxication From Smoking “Spice”
Simmons, J. R., Skinner, C. G., Williams, J., et al. (2011) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2010.08.039 · Cited by 95
Bhaskaran, M. D., & Smith, B. N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010683 · Cited by 91
Vearrier, D., & Osterhoudt, K. C. (2010) · Pediatric Emergency Care · doi:10.1097/pec.0b013e3181e4f416 · Cited by 87
Ernst, L., Schiebel, H., Theuring, C., Lindigkeit, R., & Beuerle, T. (2011) · Forensic Science International · doi:10.1016/j.forsciint.2011.03.020 · Cited by 86
Nakajima, J., Takahashi, M., Seto, T., Kanai, C., Suzuki, J., Yoshida, M., & Hamano, T. (2011) · Forensic Toxicology · doi:10.1007/s11419-011-0108-3 · Cited by 83
Macnab, A. J., ANDERSON, E., & Susak, L. E. (1989) · Pediatric Emergency Care · doi:10.1097/00006565-198912000-00010 · Cited by 74
Huffman, J. W. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-503-9_3 · Cited by 71
Cannabis-Associated Psychosis: Current Status of Research
Leweke, F. M., Gerth, C. W., & tter, J. K. (2004) · CNS Drugs · doi:10.2165/00023210-200418130-00005 · Cited by 70
Spice: A New “Legal” Herbal Mixture Abused by Young Active Duty Military Personnel
Bebarta, V. S., Ramirez, S., & Varney, S. M. (2012) · Substance Abuse · doi:10.1080/08897077.2011.637610 · Cited by 63
Coma due to cannabis toxicity in an infant
Appelboam, A., & OADES, P. J. (2006) · European Journal of Emergency Medicine · doi:10.1097/01.mej.0000194405.38206.f2 · Cited by 54
Ataxia and Shaking in a 2-Year-Old Girl
Bonkowsky, J. L., Sarco, D. P., & Pomeroy, S. L. (2005) · Pediatric Emergency Care · doi:10.1097/01.pec.0000173349.38024.33 · Cited by 50
Mortati, K. A., Dworetzky, B. A., & Devinsky, O. (2007) · PubMed · Cited by 50
Intoxication from Accidental Marijuana Ingestion
Weinberg, D. H., Lande, A. E., HILTON, N., & Kerns, D. L. (1983) · PEDIATRICS · doi:10.1542/peds.71.5.848 · Cited by 47
Cannabinoid Hyperemesis: A Case Series
Donnino, M. W., Cocchi, M. N., Miller, J. B., et al. (2009) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2009.07.033 · Cited by 47
Synthetic Cannabinoid Induced Psychosis in a Previously Nonpsychotic Patient
Peglow, S. L., Buchner, J. A., & Briscoe, G. W. (2012) · American Journal on Addictions · doi:10.1111/j.1521-0391.2012.00222.x · Cited by 46
Identification of 1-butyl-3-(1-(4-methyl)naphthoyl)indole in a herbal mixture
Westphal, F., Sönnichsen, F. D., & Thiemt, S. (2011) · Forensic Science International · doi:10.1016/j.forsciint.2011.03.031 · Cited by 44
Panic Attack after Spice Abuse in a Patient with ADHD
Müller, H., Huttner, H. B., Köhrmann, M., Wielopolski, J., Kornhuber, J., & Sperling, W. (2010) · Pharmacopsychiatry · doi:10.1055/s-0029-1243252 · Cited by 40
Blocking the Cannabinoid Receptors: Drug Candidates and Therapeutic Promises
Muccioli, G. G. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790153 · Cited by 36
Cited by
Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications
Castaneto, M. S., Gorelick, D. A., Desrosiers, N. A., Hartman, R. L., Pirard, S., & Huestis, M. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.005 · Cited by 709
Crystal Structure of the Human Cannabinoid Receptor CB1
Hua, T., Vemuri, K., Pu, M., Qu, L., Han, G. W., Wu, Y., Zhao, S., Shui, W., Li, S., Korde, A., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.004 · Cited by 673
Tait, R. J., Caldicott, D., Mountain, D., Hill, S. L., & Lenton, S. (2016) · Clinical Toxicology · doi:10.3109/15563650.2015.1110590 · Cited by 378
Novel psychoactive substances of interest for psychiatry
Schifano, F., Orsolini, L., Duccio Papanti, G., & Corkery, J. M. (2015) · World Psychiatry · doi:10.1002/wps.20174 · Cited by 321
Spicing things up: synthetic cannabinoids
Spaderna, M., Addy, P. H., & D’Souza, D. C. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3188-4 · Cited by 296
Metadata
- Authors
- Hermanns‐Clausen, M., Kneisel, S., Szabo, B., & Auwärter, V.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2012-11
- Volume
- 108
- Issue
- 3
- Pages
- 534-544
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W1883661543
- Cited by
- 479
- References
- 68
- FWCI
- 50.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.